Cti Biopharma reported $-24179000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Applied Genetic Technologies AGTC:US $ -17.12M 4.98M
Baxter International BAX:US $ 450M 152M
Bristol Myers Squibb BMY:US $ 1546M 491M
Cti Biopharma CTIC:US $ -24.18M 4.5M
Cytori Therapeutics CYTX:US $ -3.72M 0.92M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Geron GERN:US $ -26.7M 2.88M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Northwest Biotherapeutics NWBO:US 45.52M 41.11M
Novartis NVS:US $ 2758M 138M
Novartis NOVN:VX SF 2758M 138M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Sunesis Pharmaceuticals SNSS:US $ -14.91M 5.74M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
YTE INCY:US $ 181.74M 32.28M